Mitglied werden

Becton, Dickinson and Company (BDX)

Healthcare • Medical - Instruments & Supplies

48
Beobachten
$182,70
Kurs
+3,00%
Veränderung
66,19 Mrd. $
Marktkapitalisierung
-
KGV

Neumann-Score Aktienanalyse

48
von 100 Punkten
Beobachten
Bewertung??/100
Profitabilität??/100
Wachstum??/100

Score-Details freischalten

Werden Sie Mitglied und erhalten Sie Zugang zu allen Analysen.

Mitglied werden

Über Becton, Dickinson and Company

Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis catheters, vascular care and preparation products, needle-free IV connectors and extensions sets, closed-system drug transfer devices, hazardous drug detections, hypodermic syringes and needles, anesthesia needles and trays, enteral syringes, and sharps disposal systems; IV medication and infusion therapy delivery systems, medication compounding workflow systems, automated medic ...

CEO
Thomas E. Polen Jr.
Mitarbeiter
70.000
Land
US